Clinical Trial Finder

Search for recruiting clinical trials or get personalized matches based on your health profile.

Featured Trials

Recruiting studies in women's health. Sign in and complete your health profile for personalized matches.

RECRUITINGNA

RESET System Pivotal Trial (Rev F)

A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the RESET System for Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity, the STEP-1 Study. A multi-center, double-blinded, randomized, sham-controlled trial to evaluate the safety and effectiveness of the RESET System plus moderate intensity lifestyle and dietary counseling compliant with 2024 ADA Standard of Care as compared to a sham control receiving moderate intensity lifestyle an

Sponsor: Morphic Medical Inc.Enrollment: 264Conditions: Diabetes type2, Obesity
Washington D.C., District of Columbia, United States | Miami, Florida, United States | Boston, Massachusetts, United States +2 more
NCT04101669
RECRUITINGPHASE3

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation therapy \[IGRT\] and chemotherapy followed by immunotherapy with durvalumab or targeted therapy with osimertinib) versus the usual treatment alone in treating patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (locally advanced) and cannot be treated by surgery (inoperable). SBRT uses special equipment to p

Sponsor: NRG OncologyEnrollment: 474Conditions: Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8
Birmingham, Alabama, United States | Birmingham, Alabama, United States | Daphne, Alabama, United States +2 more
NCT05624996
RECRUITINGPHASE3

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Researchers are looking for new ways to treat metastatic cervical cancer. Cervical cancer is cancer in the cervix, the lower part of the uterus (womb). Metastatic means the cancer has spread to other parts of the body. Researchers want to learn about giving the study medicine sacituzumab tirumotecan (also called sac-TMT or MK-2870) along with pembrolizumab and bevacizumab treatments. Sac-TMT is an antibody drug conjugate, which is a type of medicine that attaches to specific targets on cancer c

Sponsor: Merck Sharp & Dohme LLCEnrollment: 1023Conditions: Cervical Cancer
Miami Beach, Florida, United States | West Palm Beach, Florida, United States | Atlanta, Georgia, United States +2 more
NCT07216703
RECRUITING

The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

People with chronic kidney disease (CKD) often experience faster aging of the heart and blood vessels, which raises the risk of heart problems beyond traditional factors like high blood pressure or cholesterol. One early sign is reduced blood flow in the tiny vessels that supply the heart, measured by a positron emission tomography (PET) scan using a marker called myocardial flow reserve (MFR). In CKD, ongoing inflammation and abnormal blood vessel growth can damage these small vessels, leading

Sponsor: Brigham and Women's HospitalEnrollment: 80Conditions: Chronic Kidney Disease, Kidney Transplant, Coronary Microvascular Dysfunction (CMD)
Boston, Massachusetts, United States
NCT07222683
RECRUITINGPHASE4

Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms

The goal of this clinical trial is to learn how three current insomnia therapies (trazodone, daridorexant, cognitive behavioral therapy for insomnia) compare with each other in peri- and post-menopausal women. It will also learn about the safety of the treatments. The main questions it aims to answer are: Which commonly used insomnia therapies are most effective and safe for improving insomnia symptoms in peri- and post-menopausal people? How well do the treatments work for people from differe

Sponsor: Brigham and Women's HospitalEnrollment: 1000Conditions: Menopausal Women, Insomnia
Boston, Massachusetts, United States | Novi, Michigan, United States | Winston-Salem, North Carolina, United States +2 more
NCT07136415

We use cookies for authentication and to improve your experience. Learn more